SCA ECHO Week on Demand

90 $

Categories: ,

SCA ECHO Week on Demand

SCA ECHO Week on Demand contains sessions presented by the Society of Cardiovascular Anesthesiologists at the 18th Annual Comprehensive Review & Update of Perioperative Echo.

Date of Release: March 24, 2015
Program End Date: March 23, 2016

Features of SCA ECHO Week on Demand include:

  • Presenters’ slides with fully synchronized audio as it was shown in the room
  • Online access to programs within 24 hours
  • Compact and convenient USB for complete access offline
  • Mobile Streaming for viewing on most iPad®, iPhone® and Android™ devices
  • Downloadable MP3 files for audio on-the-go

The mission of the Society’s CME program is to provide anesthesiologists, through a broad variety of educational meetings, enduring materials, and electronic media, with the information and skills that will reinforce their knowledge base and introduce new concepts and clinical practice skills involving the perioperative care of patients with cardiovascular and thoracic disease. It is expected that these educational opportunities will enhance the practitioners’ clinical practice skills.

Program Objectives

Fundamentals of Echocardiography
The format of this program will include didactics, workshops, and small group interactive case discussions to review the role of perioperative echocardiography in diagnosing cardiac and great vessel pathology in patients undergoing cardiac and noncardiac procedures or interventions in surgical or other clinical settings.

Upon completion of this course, the participant will be able to understand the application of echocardiographic principles, including the physics of ultrasound and Doppler echocardiography, and hemodynamic quantification. Course participants will have a better understanding of the pathophysiology of valvular
heart disease, cardiac function and dysfunction, and diseases of the great vessels.

Upon completion of this educational activity, the participant should be able to

  • apply the essential principles of 2D echocardiography and spectral and color Doppler echocardiography in clinical settings
  • recognize the components of the comprehensive perioperative echocardiographic examination
  • identify cardiac and great vessel anatomy and evaluate the function of the ventricles and heart valves
  • describe common artifacts and misinterpretations of normal cardiac anatomy
  • perform echocardiographic measurements essential for clinical decision making
  • recognize the role of echocardiography in the identification of diastolic dysfunction in heart failure
  • diagnose the basic congenital cardiac anomalies.

Application of Echocardiography
Upon completion of this educational activity, the participant should be able to

  • assess types, establish severity, and determine etiology of various types of mitral regurgitation
  • recognize the role of echocardiography in the identification of diastolic dysfunction in heart failure
  • delineate the role of perioperative echocardiography in guiding surgical decision making for cardiac patients undergoing valve repair or replacement, thoracic aortic repair, and mechanical circulatory support
  • describe the approach to echocardiographic assessment of unexpected valve lesions in patients undergoing valve repair/replacement
  • explain the echocardiographic evaluation of ventricular assist devices to support the separation from cardiopulmonary bypass
  • list the role of perioperative echocardiography in percutaneous procedures commonly performed in the catheterization lab or hybrid operating room
  • describe the interaction between the different specialties—surgeons, cardiologists, and anesthesiologists—in complex decision-making processes involved in the perioperative care of surgical patients with cardiovascular disease
  • list the essential elements for obtaining training and certification to establish competence in basic and advanced perioperative echocardiography.Porcine Heart Wet Lab: Hands-On Dissection with Echocardiographic and Surgical Correction

Upon completion of this educational activity, the participant should be able to:

  • Identify cardiac and great vessel anatomy in the porcine heart
  • Correlate porcine anatomical structures to 2D echocardiographic structures
  • Correlate porcine anatomical structures to surgical anatomic landmarks.

Fundamentals of 3D Echocardiography and Tissue Doppler, Strain, and Speckle
This program will review the role of new and innovative imaging techniques in perioperative decision-making. It will include both large-group didactics and rotating, interactive, small-group instruction and case discussions. The participant will gain a better understanding of how to incorporate innovative imaging into daily practice.

Upon completion of this educational activity, the participant should be able to

  • recognize and acquire routine 3D echocardiographic images
  • perform basic manipulation and measurements of 3D datasets
  • recognize and acquire images for tissue Doppler analysis
  • describe cardiac deformation with Doppler and speckle imaging
  • incorporate these modalities in clinical decision making.

Accreditation statement
The Society of Cardiovascular Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Society of Cardiovascular Anesthesiologists designates this enduring material for a maximum of  37 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Faculty List, Credentials and Disclosures

The following faculty members, chairpersons, and speakers have indicated, in accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards and SCA policy, that they or a member of their immediate household do not have a relationship with any commercial interests that produce, market, re-sell, or distribute healthcare goods or services consumed by or used on patients and that are discussed in their educational presentation or that have provided commercial support for this CME activity. Such relationships include, but are not limited to, member of the board of directors, advisory board, or speakers’ bureau; participant in industry-sponsored research; recipient of a research grant; employee; investor; and consultant. Such relationships will be communicated to registrants in final course materials and in presentation slides on site prior to the session. Invited speakers have agreed that their presentations will be objective, they will provide a balanced view of diagnostic and therapeutic options, and discussion of any off-label or investigational use of a commercial product will be disclosed to the audience.

Edwin Avery, MD
Daniel Drake, MD
Sidney Edelman, PhD
Meghann Fitzgerald, MDJohn A. Fox, MD
Gregg S. Hartman, MD
Lori Heller, MD
Jonathan Ho, MDFeroze Mahmood, MD
Andrew Maslow, MD
Alina Nicoara, MD FASE
Charles Nyman, MBBCh
Peter Panzica, MD
Kent H. Rehfeldt, MD FASE
Robert M. Savage, MD FACC
Jack Shanewise, MD FASE
Sasha K. Shillcutt, MD FASE
Nikolaos J. Skubas, MD FASE
Michele Sumler, MD
Madhav Swaminathan, MD FASE
Mark A. Taylor, MD FASE
Annemarie Thompson, MD
Christopher A. Troianos, MD
Annette Vegas, MDCM FRCPC FASE

The following faculty members, chairpersons, and speakers have indicated, in accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards and SCA policy, that they or a member of their immediate household have a relationship with any commercial interests that produce, market, re-sell, or distribute healthcare goods or services consumed by or used on patients and that are discussed in their educational presentation or that have provided commercial support for this CME activity. Such relationships include, but are not limited to, member of the board of directors, advisory board, or speakers’ bureau; participant in industry-sponsored research; recipient of a research grant; employee; investor; and consultant. Such relationships will be communicated to registrants in final course materials and in presentation slides on site prior to the session. Invited speakers have agreed that their presentations will be objective, they will provide a balanced view of diagnostic and therapeutic options, and discussion of any off-label or investigational use of a commercial product will be disclosed to the audience.

Nature of Relationship Key

1. No relevant financial relationships
2. Advisory board member
3. Board of directors
4. Consultant
5. Employee
6. Expert reviewer
7. Expert testimony
8. Founder
9. Independent contractor
10. Principal investigator
11. Speakers’ bureau
12. Stock holder
13. Other

Bruce Bollen, MD: Chest Innovations, 12
Thomas Burch, MD: PTEmasters.com, 13
Albert T. Cheung, MD: Covidien, 4; Uptodate, 13
Kathryn Glas, MD MBA FASE: Lippincott Williams & Wilkins, 13
Katherine Grichnik, MD FASE: Novartis, 4; Amgen, 4; Castle Biologics, 4; Digital Derm, 4
Jonathan D. Leff, MD: Casmed Systems, 4
Matt Maxwell, MD: Medtronic Corp., 11
Donald Oxorn, MD CM FRCPC FACC: Sonosite, 4
Stanton K. Shernan, MD FAHA FASE: E-Echocardiography, 13; Philips, 13

Douglas Shook, MD FASE: St. Jude Medical, 13; Edwards Lifesciences, 13; Sorin Group, 13
Roman M. Sniecinski, MD FASE: Covidien, 10; Grifols, 2, 10; Shire ViroPharma, 10
Vinod Thourani, MD FACS FACC: Edwards Lifesciences, 10

 

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related Products